Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Michelle M. Nuño"'
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 9, Iss 4, Pp n/a-n/a (2023)
Abstract INTRODUCTION Alzheimer's disease (AD) trials require enrollment with an informant. METHODS We assessed relationships between informant replacement and Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS‐ADL) scores acros
Externí odkaz:
https://doaj.org/article/7959d1c5396148068726c7d63efad7eb
Autor:
Michelle M. Nuño, Daniel L. Gillen, Joshua D. Grill, for the Alzheimer’s Disease Cooperative Study
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-7 (2019)
Abstract Background Alzheimer’s disease (AD) clinical trials require enrollment of a participant and a study partner, whose role includes assessing participant cognitive and functional performance. AD trials now investigate early stages of the dise
Externí odkaz:
https://doaj.org/article/4f9a50e6b8f74e5c9ab51d70d8746ad1
Autor:
Michelle M. Nuño, Daniel L. Gillen, Kulwant K. Dosanjh, Jenny Brook, David Elashoff, John M. Ringman, Joshua D. Grill
Publikováno v:
Alzheimer’s Research & Therapy, Vol 9, Iss 1, Pp 1-10 (2017)
Abstract Background Research has revealed that manifest Alzheimer’s disease (AD) dementia is preceded by preclinical and prodromal phases during which pathology is accumulating but function remains intact. This understanding and concern that diseas
Externí odkaz:
https://doaj.org/article/28c33ea2481c4bd780d5af51a273e87b
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Christian D. Fankhauser, Michelle M. Nuño, Matthew J. Murray, Lindsay Frazier, Aditya Bagrodia
Publikováno v:
European Urology Focus. 8:660-662
Testicular germ cell tumours (GCTs) are the most common malignancy among young men. Management of GCTs relies on the serum tumour markers α-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase, among other parameters. However, these
Autor:
Daniel L. Gillen, Michelle M. Nuño
Publikováno v:
Stat Med
Time-dependent receiver operating characteristic curves are often used to evaluate the classification performance of continuous measures when considering time-to-event data. When one is interested in evaluating the predictive performance of multiple
Autor:
Marina Ritchie, Megan Witbracht, Michelle M. Nuño, Dan Hoang, Daniel L. Gillen, Joshua D. Grill
Publikováno v:
Journal of Alzheimer's disease : JAD. 90(3)
Background: Clinical trials now test promising therapies in the preclinical stages of Alzheimer’s disease (AD). Participant willingness to enroll in different types of preclinical AD trials is understudied and whether the FDA approval of aducanumab
Publikováno v:
Clin Trials
Clinical trials (London, England), vol 18, iss 6
Clinical trials (London, England), vol 18, iss 6
Background/Aims: The focus of Alzheimer’s disease studies has shifted to earlier disease stages, including mild cognitive impairment. Biomarker inclusion criteria are often incorporated into mild cognitive impairment clinical trials to identify ind
Autor:
Daniel L. Gillen, Michelle M. Nuño
Publikováno v:
Scandinavian Journal of Statistics. 49:265-286
Autor:
Michelle M. Nuño, John T. Lafin, Isabella Syring, James F. Amatruda, Aditya Bagrodia, Mark Krailo, A. Lindsay Frazier, Jin Piao, Cinzia G. Scarpini, Jörg Ellinger, Gazanfer Belge, Nicholas Coleman, Klaus Peter Dieckmann, Matthew J. Murray
Publikováno v:
Clin Genitourin Cancer
Objective : Circulating microRNAs have clear potential for improving malignant germ-cell-tumor (MGCT) diagnosis. Here, we address the central issue of whether measurement of a single microRNA is sufficient for detecting testicular MGCTs, or whether t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50667f723df4b4f7b171279983195fdd